Abstract
With the discovery of COX, pain has not been treated in a relentless manner. Numbers of drugs with fewer side effects were discovered and are used successfully for treatment of pain. With new research coming into being since the discovery of COX, it was established that COX can be targeted not only for treatment of pain but for curing various diseases like cancer, Alzheimer’s, Parkinson’s disease, Glaucoma etc. With the sighting of COX-3, another isoform of COX, new diseases are being targeted for better treatment.
Keywords: Anticancer, COX, COX-3, cyclooxygenase, inflammation, NSAIDs, pain.
Graphical Abstract
Inflammation & Allergy - Drug Targets (Discontinued)
Title:The Ambidextrous Cyclooxygenase: An Enduring Target
Volume: 13 Issue: 6
Author(s): Mayank Bapna and Lalit Singh Chauhan
Affiliation:
Keywords: Anticancer, COX, COX-3, cyclooxygenase, inflammation, NSAIDs, pain.
Abstract: With the discovery of COX, pain has not been treated in a relentless manner. Numbers of drugs with fewer side effects were discovered and are used successfully for treatment of pain. With new research coming into being since the discovery of COX, it was established that COX can be targeted not only for treatment of pain but for curing various diseases like cancer, Alzheimer’s, Parkinson’s disease, Glaucoma etc. With the sighting of COX-3, another isoform of COX, new diseases are being targeted for better treatment.
Export Options
About this article
Cite this article as:
Bapna Mayank and Chauhan Singh Lalit, The Ambidextrous Cyclooxygenase: An Enduring Target, Inflammation & Allergy - Drug Targets (Discontinued) 2014; 13 (6) . https://dx.doi.org/10.2174/1871528114666150401105545
DOI https://dx.doi.org/10.2174/1871528114666150401105545 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Herpesvirus / Retrovirus Chimeric Vectors
Current Gene Therapy Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer
Current Pharmaceutical Design Editorial [Hot topic: Target Therapy of Bone Metastases and Tumours (Guest Editors: M. Caraglia and D. Santini)]
Current Cancer Drug Targets Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Current Cancer Drug Targets Injectable Thermosensitive Chitosan/Glycerophosphate-Based Hydrogels for Tissue Engineering and Drug Delivery Applications: A Review
Recent Patents on Drug Delivery & Formulation MiR-134, Mediated by IRF1, Suppresses Tumorigenesis and Progression by Targeting VEGFA and MYCN in Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry Development and Current Status of Unconventional Platinum Anticancer Complexes
Mini-Reviews in Medicinal Chemistry Promiscuous Binding Nature of Sh3 Domains to their Target Proteins
Protein & Peptide Letters Connecting Small Molecules to Nuclear Receptor Pathways
Current Topics in Medicinal Chemistry Targeted Ultrasound Imaging of Cancer: An Emerging Technology on its Way to Clinics
Current Pharmaceutical Design HIV and Respiratory Disease: A Contemporary Perspective
Current Respiratory Medicine Reviews Urokinase-a Very Popular Cardiovascular Agent
Recent Patents on Cardiovascular Drug Discovery JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases
Current Drug Targets c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?
Current Cancer Drug Targets Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
Current Genomics Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
Current Cancer Drug Targets CXCR4 Receptor as a Promising Target for Oncolytic Drugs
Mini-Reviews in Medicinal Chemistry The Applicability of mTOR Inhibition in Solid Tumors
Current Cancer Drug Targets Cratylia mollis Lectin: A Versatile Tool for Biomedical Studies
Current Bioactive Compounds